On August 15, 2023, the Minister of Health announced the appointment of Anie Perrault as Vice Chairperson of the Patented Medicine Prices Review Board (PMPRB) for a five-year term. According to the announcement, Ms. Perrault has over 30 years of experience in the public and private sectors, having held positions in the genomic research and biotechnology sector in Quebec and nationally.
On August 22, 2023, the PMPRB published the seventh edition of its annual Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries. The 2023 report examines trends in new medicine approvals and sales internationally and in Canada from 2016-2021, with a focus on medicines approved in 2020 and 2021.
Related Publications & Articles
-
CIPO will not issue patents on July 9 or July 16
The Canadian Intellectual Property Office (CIPO) will be launching a new online portal for patent services, MyCIPO Patents, on July 15, 2024.Read More -
PMPRB releases Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines
On June 26, 2024, the Patented Medicine Prices Review Board (PMPRB) released a Discussion Guide for its Phase 2 Consultations on its New Guidelines.Read More -
2024 mid-year highlights in Canadian life sciences IP and regulatory law
In the first half of 2024, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. The Rx IP Update team at Smart & Biggar has collected the top stories ...Read More